Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D6W2MF
|
|||
| Drug Name |
ST-400
|
|||
| Drug Type |
Cell therapy
|
|||
| Indication | Beta thalassemia [ICD-11: 3A50.2; ICD-10: D56.1, D56.3] | Phase 1/2 | [1] | |
| Company |
Sanofi; Sangamo Therapeutics
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03432364) A Study to Assess the Safety, Tolerability, and Efficacy of ST-400 for Treatment of Transfusion-Dependent Beta-thalassemia (TDT). U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.